Flex, a Singapore-based electronics manufacturing firm, has opened Flex Chennai Industrial Park 3, its new manufacturing facility in Walajabad, Tamil Nadu, India. According to the sketch-to-scale solutions provider, Flex Chennai Industrial Park 3 with 159,000 ft2 of space will further increase the company’s manufacturing operations in the country. Commenting on the launch of the plant, […]
Lakshmi Manchu is all set to make a comeback in the small screen with a stunt-based reality show that will feature popular film and TV […]
Real estate industry news : Longfellow Real Estate Partners has acquired the Palo Alto Technology Center (PATC) in Palo Alto, California from private equity real estate company KBS for $205 million. The purchase of the Palo Alto Technology Center marks the fifth acquisition in the US West Coast since late 2018 for Longfellow Real Estate […]
Mylan Upjohn merger : US pharma giant Pfizer will spin off Upjohn, its off-patent branded and generic established medicines business,
The post Mylan Upjohn merger : Pfizer to merge off-patent drugs unit with Mylan appeared first on PharmaNewsDaily.com.
Food acquisition news : Italian confectionery group Ferrero has wrapped up its previously announced $1.3 billion acquisition of the cookie, fruit and fruit-flavored snack, ice cream cone and pie crust businesses from Kellogg. Through the deal, Ferrero has acquired a cookie portfolio that includes the Keebler cookies brand, Famous Amos cookies, Murray sugar-free cookies, family […]
Ponesimod OPTIMUM trial results : Johnson & Johnson’s Janssen Pharmaceutical said that the phase 3 OPTIMUM clinical trial evaluating ponesimod
The post Janssen’s Ponesimod OPTIMUM trial in MS meets primary endpoint appeared first on PharmaNewsDaily.com.
Ofev FDA approval recommendation: The US FDA’s Arthritis Advisory Committee has recommended approval of Boehringer Ingelheim’s kinase inhibitor Ofev (nintedanib)
The post Boehringer Ingelheim secures Ofev FDA approval recommendation for SSc-ILD appeared first on PharmaNewsDaily.com.
KSI-301 phase 1b results : Kodiak Sciences, a California-based retinal medicines development company, said that a phase 1b clinical trial
The post Kodiak Sciences reports positive KSI-301 phase 1b results appeared first on PharmaNewsDaily.com.
NeuroSTAT FDA fast track designation : Swedish mitochondrial medicine company NeuroVive Pharmaceutical has secured Fast Track designation from the US
The post NeuroVive secures NeuroSTAT FDA fast track designation for TBI appeared first on PharmaNewsDaily.com.
T-Mobile Sprint merger update : The US Department of Justice has cleared the proposed $ 26 billion merger of T-Mobile US and Sprint to create New T-Mobile following both the companies’ agreements with DISH Network. Under the deal with DISH, New T-Mobile will divest all Sprint’s pre-paid businesses, including Boost Mobile and Virgin Mobile, and […]